E
Regen BioPharma, Inc. RGBP
$0.055 $0.0011.85% OTC PK
Recommendation
Prev Close
$0.054
Volume
993
Avg Vol (90D)
18,734
Market Cap
$1.16M
Dividend & Yield
--
52-Week Range
$0.02 - $0.60
P/E (TTM)
--
EPS (TTM)
-$0.1073
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$236.70K
EBITDA (TTM)
--
EBIT (TTM)
-$418.30K
Net Income (TTM)
-$867.30K
Balance Sheet
Total Assets (Q)
$177.60K
Total Debt (Q)
$794.70K
Total Liabilities (Q)
$5.37M
Book Value Per Share (Q)
-$0.494
Cash Flow
Cash from Operations (TTM)
-$693.10K
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$572.80K
Net Change in Cash (TTM)
-$120.30K
Filings
Filing Date
Monday, October 28, 2024
Period Date
Monday, September 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
0.53
7-Day Total Return
-15.25%
30-Day Total Return
0.00%
60-Day Total Return
-11.43%
90-Day Total Return
-45.00%
Year to Date Total Return
-8.49%
1-Year Total Return
-84.29%
2-Year Total Return
-94.50%
3-Year Total Return
-98.91%
5-Year Total Return
-26.67%
52-week Low
Nov 11, 2024 - $0.02
52-week High
Jun 03, 2024 - $0.60
Valuation
Market Cap
$1.16M - Nano Cap
Enterprise Value
$1.96M
Price/Sales (TTM)
2.07
Price/Book (Q)
-0.11
Dividends and Shares
Shares Outstanding
9.04M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
regenbiopharmainc.com
Phone Number
619 722 5505
Address
4700 Spring Street
La Mesa, CA 91942
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to... more
OTC PK 04/28/2025 9:30AM Eastern Quotes delayed